NCT02525250View on ClinicalTrials.gov

Pilot Study Immunomonitoring Natural Killers Cells in Patients With Myeloid Malignancies Treated With Lenalidomide

NACompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Acute Myeloid Leukemia or Myelodysplasic Syndrome
Interventions
PROCEDURE

Realization of 3 Blood samples during study during treatment with lenalidomide

Trial Locations (1)

13009

Thomas PREBET, MD, Marseille

All Listed Sponsors
lead

Institut Paoli-Calmettes

OTHER

NCT02525250 - Pilot Study Immunomonitoring Natural Killers Cells in Patients With Myeloid Malignancies Treated With Lenalidomide | Biotech Hunter | Biotech Hunter